Research Pathways
- Research Pathways
  Bringing new therapies from the lab to patients
- Percorso della ricerca
  Portare nuove terapie dal laboratorio ai pazienti
- ATMP Engage
  Advanced Therapy Medicinal Products Patient and Public Involvement and Engagement Working Group
- Actors and Network database
  Actors and Networks database
Bringing new therapies from the lab to patients
Scoperta
- Scoperta
  Scopri di più su terapia genica e cellulare
- Educational Resources Directory
  Educational Resources Directory
- INTENS
  INtestinal Tissue ENgineering Solution
- LEARN
  Listening to the experience of participants in neurosurgical trials
Scopri di più su terapia genica e cellulare
Chi Siamo
Il nostro gruppo e i nostri collaboratori
Contatti

Condizione

Atrofia Muscolare Spinale
Cancro
Diabete
Distrofia muscolare
Epidermiolisi bullosa
Ischemia cerebrale
Lesioni del midollo spinale
Malattia di Alzheimer
Malattia di Huntington
Malattia di Parkinson
Malattie autoimmuni
Malattie cardiache
Malattie dei polmoni
Malattie del sangue
Malattie dell'occhio
Malattie epatiche
Malattie intestinali
Malattie muscolo-scheletriche
Malattie neurologiche
Malattie rare
Malattie renali
Paralisi cerebrale
Pelle
Sangue del cordone ombelicale
Sclerosi laterale amiotrofica
Sclerosi multipla
Riproduzione e fertilità

Tema

Cellule iPS
Cellule staminali del sangue
Cellule staminali della pelle
Cellule staminali embrionali
Cellule staminali mesenchimali
Coinvolgimento del paziente
Editing genetico
Etica e società
Industria
Ingegnerizzazione dei tessuti
Metodi e Strumenti
Modello sperimentale di malattia
Norme e regolamenti
Notizie sulle Cellule Staminali
Organoidi
Principi base di Cellule e Geni
Ricerca
Riprogrammazione
Sangue cordonale
Schede Informative
Scopri le cellule staminali
Studi clinici
Terapia CAR-T
Terapia cellulare
Terapia genica
Trattamenti non dimostrati
Uso attuale e potenziale

Seleziona una lingua

English
Français
Deutsch
Italiano
Polski
Español
Português

ATMP Engage PPI Directory

The PPI Directory contains patient and public involvement (PPI) resources for developers of cell and gene therapies, including toolkits, guidelines, advice, templates and case studies.

Breadcrumb

ATMP Engage
PPI Directory

PPI Directory

Title

PPI Themes

PPI Themes
- PPI Basics and Benefits
- Standards for PPI
- Roles and Responsibilities
- PPI Pools/Lists of Organisations
- Knowledge Building
- Strategies/Statements/Policies on PPI
- Budgeting/Compensation
- Project Planning
- How/Who to Recruit
- Using Technology
- Training
- Maintaining/Supporting PPI
- Communication/Plain Language/Glossaries
- Case Studies
- Evaluating/Recording PPI Impact
- Feedback to/from PPI

Research Field

Research Field
- General
- Biomedical Lab
- Pharmaceutical
- ATMP/Gene Therapy Development
- Other

Organisation Type

Organisation Type
- Funder
- Academia
- Healthcare
- Regulatory Body
- HTA
- Industry
- Third Sector/Charity
- Other Organisation

Development Stage

Development Stage
- Identifying/Prioritising Patient Need
- Research and Clinical Development
- Regulatory Approval
- Health Technology Assessment
- Service Delivery

Audience

Audience
- Researchers/Developers
- Public/Patients
- Charity Sector
- Industry
- Other groups

Country

Country
- UK
- Europe
- North America
- Other countries

Content Type

Content Type
- Resource
- Journal
- Repository
- Article

toolkit
partnership
NHS

PPI Pools/Lists of Organisations✕
Knowledge Building✕

Showing 5 of 86 results.

Page 6 of 18

2021

ATTC Advanced Therapies Events

The Advanced Therapy Treatment Centre (ATTC) webinar series on cell and gene therapies

Visit this Resource

Research Field

ATMP/Gene Therapy Development

Organisation Type

Other Organisation

Development Stage

Service Delivery

Audience

Public/Patients

Country

Content Type

Resource

2021

MHRA Patient Involvement Strategy 2021-25

Report outlining how the Medicines and Healthcare products Regulatory Agency (MHRA) will engage patients in their work

Visit this Resource

Research Field

Other

Organisation Type

Regulatory Body

Development Stage

Regulatory Approval

Audience

Public/Patients

Country

Content Type

Resource

Opportunities for patients and the public to be involved in the work of the MHRA

Information on how patients can be involved in work by the Medicines and Healthcare products Regulatory Agency (MHRA)

Visit this Resource

Research Field

Other

Organisation Type

Regulatory Body

Development Stage

Regulatory Approval

Audience

Public/Patients

Country

Content Type

Resource

2021

MHRA Proposed Patient and Public Involvement Strategy 2020-25

Details from a public consultation on the proposed strategy for involving patients in the Medicines and Healthcare products Regulatory Agency (MHRA)

Visit this Resource

Research Field

Other

Organisation Type

Regulatory Body

Development Stage

Regulatory Approval

Audience

Public/Patients

Country

Content Type

Resource

Public Involvement Network Advisory Group Terms of Reference

Terms of reference for patient carer representatives that help inform Scottish Medicines Consortium (SMC) processes, published by Healthcare Improvement Scotland (HIS) and SMC

Visit this Resource

Research Field

ATMP/Gene Therapy Development

Organisation Type

Third Sector/Charity

Development Stage

Health Technology Assessment
Service Delivery

Audience

Researchers/Developers
Public/Patients
Charity Sector
Industry

Country

Content Type

Resource

Pagination

First page
Previous page
…
Pagina 4
Pagina 5
Pagina 6
Pagina 7
Pagina 8
…
Next page
Last page

Who are we?

The Advanced Therapy Medicinal Products Patient and Public Involvement and Engagement Working Group (ATMP Engage) brings together UK-based stakeholders with an interest in ATMPs to discuss and collaborate on PPIE activity.

Learn more about ATMP Engage

Torna in alto

Footer menu

Termini e condizioni
Privacy
Accessibilità
Contattaci

EuroGCT su Facebook EuroGCT su Twitter